208 related articles for article (PubMed ID: 29601082)
1. Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.
Navidi M; Phillips AW; Griffin SM; Duffield KE; Greystoke A; Sumpter K; Sinclair RCF
Br J Surg; 2018 Jun; 105(7):900-906. PubMed ID: 29601082
[TBL] [Abstract][Full Text] [Related]
2. The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma.
Sinclair R; Navidi M; Griffin SM; Sumpter K
Ann R Coll Surg Engl; 2016 Jul; 98(6):396-400. PubMed ID: 27138851
[TBL] [Abstract][Full Text] [Related]
3. Routine pre- and post-neoadjuvant chemotherapy fitness testing is not indicated for oesophagogastric cancer surgery.
Drummond RJ; Vass D; Wadhawan H; Craig CF; MacKay CK; Fullarton GM; Forshaw MJ
Ann R Coll Surg Engl; 2018 Sep; 100(7):515-519. PubMed ID: 29692190
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserve.
Chmelo J; Phillips AW; Greystoke A; Bradshaw A; Sinclair RCF
Br J Surg; 2021 Oct; 108(10):e328-e329. PubMed ID: 34291278
[No Abstract] [Full Text] [Related]
5. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.
Jack S; West MA; Raw D; Marwood S; Ambler G; Cope TM; Shrotri M; Sturgess RP; Calverley PM; Ottensmeier CH; Grocott MP
Eur J Surg Oncol; 2014 Oct; 40(10):1313-20. PubMed ID: 24731268
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection.
West MA; Baker WC; Rahman S; Munro A; Jack S; Grocott MP; Underwood TJ; Levett DZ;
J Surg Oncol; 2021 Dec; 124(8):1306-1316. PubMed ID: 34463378
[TBL] [Abstract][Full Text] [Related]
7. Real-life data on improvement of survival after perioperative chemotherapy versus surgery alone on resectable adenocarcinoma of the stomach - a single-center study.
Kuhnle PJ; Israel KF; Menges M
Z Gastroenterol; 2019 May; 57(5):606-610. PubMed ID: 31083749
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction.
Samel S; Hofheinz R; Hundt A; Sturm J; Knoll MR; Wenz F; Queisser W; Post S
Onkologie; 2001 Jun; 24(3):278-82. PubMed ID: 11455222
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma.
Solomon N; Mezentsev D; Reis I; Lima M; Rios J; Avisar E; Franceschi D; Livingstone A; Podolsky L; Ardalan B
Jpn J Clin Oncol; 2011 Apr; 41(4):469-76. PubMed ID: 21258083
[TBL] [Abstract][Full Text] [Related]
10. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
11. Poor performance in incremental shuttle walk and cardiopulmonary exercise testing predicts poor overall survival for patients undergoing esophago-gastric resection.
Whibley J; Peters CJ; Halliday LJ; Chaudry AM; Allum WH
Eur J Surg Oncol; 2018 May; 44(5):594-599. PubMed ID: 29459017
[TBL] [Abstract][Full Text] [Related]
12. Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer.
Sylvie L; Silvia S; Salah-Eddin AB; Markus F; Florian L; Peter TP; Bernhard H; Martin A; Alexander N
Eur J Cancer; 2015 Sep; 51(14):1918-26. PubMed ID: 26216588
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis K; Bassermann F; Schuhmacher C; Voelter V; Busch R; Roethling N; Sendler A; Siewert JR; Peschel C; Lordick F
Ann Thorac Surg; 2006 Jul; 82(1):293-7. PubMed ID: 16798232
[TBL] [Abstract][Full Text] [Related]
14. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
Chua YJ; Cunningham D
Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
[No Abstract] [Full Text] [Related]
15. Preoperative Peak Oxygen Uptake in Lung Cancer Subjects With Neoadjuvant Chemotherapy: A Cross-Sectional Study.
Fresard I; Licker M; Adler D; Lovis A; Robert J; Karenovics W; Diaper J; Janssens JP; Triponez F; Lador F; Rochat T; Espinosa V; Bhatia C; Kayser B; Bridevaux PO
Respir Care; 2016 Aug; 61(8):1059-66. PubMed ID: 27165422
[TBL] [Abstract][Full Text] [Related]
16. Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer.
Téoule P; Trojan J; Bechstein W; Woeste G
Dig Surg; 2015; 32(4):229-37. PubMed ID: 25966823
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary fitness predicts postoperative major morbidity after esophagectomy for patients with cancer.
Patel N; Powell AG; Wheat JR; Brown C; Appadurai IR; Davies RG; Bailey DM; Lewis WG
Physiol Rep; 2019 Jul; 7(14):e14174. PubMed ID: 31342676
[TBL] [Abstract][Full Text] [Related]
18. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
[TBL] [Abstract][Full Text] [Related]
19. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
